Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s):  SZLSF

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease... see more

TSX:SZLS - Post Discussion

StageZero Life Sciences Ltd > Literally 0 tests sold?
View:
Post by molotov421 on Nov 15, 2023 12:30am

Literally 0 tests sold?

"With the significant decline in COVID revenue in 2022, management has re-focused on its operations respecting
cancer testing and care. Consequently, the Company has one reportable operating segment, operating in two major
geographic areas, North America and Western Europe."

Aristotle and covid used to be reported under "lab operations" which apparently is no longer a thing now that covid is gone...wow!
Comment by Jonnyboy85 on Nov 15, 2023 12:48am
 METRICS Study Informs Expansion of StageZero's New Care Oncology Protocol 2; establishes pathway to METRICS II and Glioblastoma addition to Aristotle. • COC clinics on path to full profitability by year end 2023  • Scaled up Aristotle/AVRT early cancer testing with Fire Fighters in the Greater Toronto Area. • Aristotle Employer programs gaining traction. : • .Position Aristotle  ...more  
Comment by Liked2Think on Nov 15, 2023 1:25am
blah blah blah more bs that doesnt create revenue hence why your god Tripp wont put one penny of his own money into the stock.
Comment by Spideysenses20 on Nov 15, 2023 1:45am
Don't know why your arguing with Johnny boy he's paid to do this, we all can see what's going on and if we have to come on here every once in a while to bring truth then so be it pretty soon Johnny boy will lose his job when Tripp has no more funding to pay him
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities